Clinical Trial Update: Study in Elderly Alzheimer's Patients to Assess Skin Tolerability, Irritation With 3, 7-Day Applications of DTP-System [Phase 2]

View source ↗

Summary

Phase 2 trial assessing skin tolerability and irritation with 3- and 7-day applications of the DTP-System in elderly Alzheimer's patients has completed; results…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Snippet

Sponsor: Teikoku Pharma USA, Inc. | Conditions: Irritation/Irritant | Phase 2 | Status: COMPLETED | Results posted: 2016-04-22